CA1287881C - Power supply for body implant - Google Patents
Power supply for body implantInfo
- Publication number
- CA1287881C CA1287881C CA000513840A CA513840A CA1287881C CA 1287881 C CA1287881 C CA 1287881C CA 000513840 A CA000513840 A CA 000513840A CA 513840 A CA513840 A CA 513840A CA 1287881 C CA1287881 C CA 1287881C
- Authority
- CA
- Canada
- Prior art keywords
- winding means
- primary winding
- power factor
- implanted
- voltage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/585—User interfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
- A61M60/178—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/873—Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8237—Charging means
- A61M2205/8243—Charging means by induction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
Abstract
POWER SUPPLY FOR BODY IMPLANT
ABSTRACT
An implanted blood pump system is described wherein power for driving the pump is provided by a transcutaneous transformer having an external primary winding and an implanted secondary winding. Control of the driving voltage to the pump is provided by an implanted shunt regulator. Voltage applied to the primary winding is controlled in accordance with the power factor sensed in the primary winding.
ABSTRACT
An implanted blood pump system is described wherein power for driving the pump is provided by a transcutaneous transformer having an external primary winding and an implanted secondary winding. Control of the driving voltage to the pump is provided by an implanted shunt regulator. Voltage applied to the primary winding is controlled in accordance with the power factor sensed in the primary winding.
Description
~Q~R_&~Ph~_~QB_~QDY IM~hA~T
This invention relates to electric power supplies, and more particularly to a power supply ~or an electrical circulatory support device which is implanted within a living body.
The relatively hiyh amount of power required by circulatory s~pport devices (blood pumps), such as a : pa~tial or total artificial heart, has rendered most implantablet self-sufficient energy sources 1~ inapplicable, such as those used for a pacemaker. Only high-power, radioisotope heat sources have held any promise of sustained outputs of several watts, however, the utilization of such an energy source has been complicated by its inherent need for a miniature, high - 1~ efficiency heat engine, as wel~ as by serious .~ radiation-related problems. All other practical approaches to powering an artificial heart or circulatory assist system of some type necessarily depend on a more or less continuous flow of energy from outside the body. Results of efforts at infection-free ~ maintenance o~ long-term percutaneous connections are :~ discouraging and thus highlight the desirability, at : least for the long term, of powering such an implanted device though intact skin~
This invention relates to electric power supplies, and more particularly to a power supply ~or an electrical circulatory support device which is implanted within a living body.
The relatively hiyh amount of power required by circulatory s~pport devices (blood pumps), such as a : pa~tial or total artificial heart, has rendered most implantablet self-sufficient energy sources 1~ inapplicable, such as those used for a pacemaker. Only high-power, radioisotope heat sources have held any promise of sustained outputs of several watts, however, the utilization of such an energy source has been complicated by its inherent need for a miniature, high - 1~ efficiency heat engine, as wel~ as by serious .~ radiation-related problems. All other practical approaches to powering an artificial heart or circulatory assist system of some type necessarily depend on a more or less continuous flow of energy from outside the body. Results of efforts at infection-free ~ maintenance o~ long-term percutaneous connections are :~ discouraging and thus highlight the desirability, at : least for the long term, of powering such an implanted device though intact skin~
2~ One of the earlie~t approaches to the transmission of energy across intact skin involves the generation of a radio frequency field extending over a substantial area of the body, such that significant - power could be extracted from coils located in the vicinity of the implanted power-consuming device - itself. Placement of substantial amounts of ferrite materials within such coils to permit the capture of a greater proportion of the incident field was also investigated, a~ reported in the article by J.C.
~5 Schuder, et al. in the 1964 Transactions ACE~B.
However, difficulty has been experienced in reconciling .~.
,, . ~ :; .. ' : .
- , , .: .
. .
. , .
' .
~.~ 8 ~
the conflicting requirement of magnetic circuit geometry with a surgically feasible, variable tissue structure. In another proposed alternative design, a ~econdary coil is implanted in such a manner that the center of the coil remains accessible through a surgically constructed tunnel of skin; however, such devices have not yielded satisfactory performance.
Predominant failure modes include necrosis of the skin tunnel tissue caused by mechanical pressure and excess heat generation - see the 1975 report of I . I ,T.
Research Institute, by BruesGhke, et al., N.I~H. Report No. N01-HT-9-21~5-3, page 25.
In ~.S. Patent No. 4,143,661, issued ~arch 13, 1979, assigned to the assignee of the present invention, a so-called belt skin transformer ~BST~
system is described in which a secondary coil is implanted just below the skin of the abdomen or the thigh so that it encircles the patient's torso or leg along most of the length of the coil and lies at a location close to the skin's surface. A primary coil, in the form of an encircling belt which is greater in width than the secondary implanted coll, fits around the patient in the region just radially outward of the secondary coil. Power is supplied to the primary coil, which is then inductively coupled transcutaneously to the secondary coil, which in turn operates the device and charges and implanted storage battery~
Naturally, proper circuit design in a BST
system requires regulation of the voltage applied to the load or blood pump. Although a variety of regulatory expedients are known in the prior art, the uniqueness of the transcutaneous transformer arrangement employed in systems of this type makes the prior art of little value in predicting ideal arrangements~ X~ has been found that a ~wo tier regulation ~cheme, employing an internal regulator for , ..
, ~ .
~7~
driving the blood pump itself, and employing an external regulator for controlling voltage input to the primary winding, is particularly desirable.
Coordination of the two regulators may, of co~rse, be achieved by suitable telemetry signals. ~owever, such telemetry circuitry adds additional expense, complexity, and unreliability factors to the system.
It is an object of the present invention to provide an improved implanted blood pump system and method for operating same~
Another object of the invention is to provide an implanted blood pump system in which a highly effective means of voltage regulation is achieYed.
Another object of the invention is to provide 1~ an improved implanted blood pump system which coordinates regulation of the voltage applied to the system in accordance with load demands and without the need for telemetry monitoring.
Other objects of the invention will become apparent to those skilled in the art from the following description, taken in connection with the accompanying drawings ~herein:
- FIGURE 1 is a diagrammatic depiction of the implanted portion of a power supply system shown in ~S conjunction with a circulatory blood pump within a living human;
FIGURE 2 is a block diagram of the system illustrated in FIGURE l;
FIGURE 3 is a schematic diagram illustrating the secondary transformer of ~he system of FIGU~E 1 connected to rectifi~r, voltage regulator/ and other implanted elements including the blood pump itself (implanted load~; and FIGURE 4 is a schematic diagram of the primary winding power circuit utilized in the sy~tem of FIGURE
1 .
' .' :, , ' . ' ' ' ~ ' , ' : :, ..... ' - ' ' 9 ~78B~
~4--Very yenerally, in the implanted blood pump sy~tem of the invention, power for driving the pump is provided by a transcutaneous transformer having an external primary winding and an implanted secondary winding and an implanted shunt regulator. Ths secondary winding applies driving voltage to the pump which is controlled by the shunt regulator. The voltage applied to the system is regulated by sensing the power factor in the primary and comparing the power factor to a predetermined power factor level selected to correspond with a desired driving voltage~ The voltage level in the primary winding is adjusted to substantially equalize the sensed power factor and the predetermined power factor level.
Referring now more particularly to FIGURE 1, a blood pump in the form of a left ventricular assist device 11 is depicted implanted within the body 13 of a patient. The device is preferably of the type shown and described in U.S. Patents Nos. 4,4577673 and 4,384,829. The system also includes an implanted ; module 15 that includes electronic rectifying and control components and a standby storage battery.
The system is powered and charged via coupling to a primary coil which is constituted by an outer belt 17 having a disconnec~able belt buckle 19. A secondary coil, not visible in FIGURE 1, but designated as 21 in FIGURES 2 and 3 is implanted in the abdomen about the waist~ The primary coil 17 overlaps the secondary coil 21 and, when positioned about the waist o a wearer, is inductively coupled to the secondary coil 21. Because of the relatively large diameter of the two air core coils, a very high mayne~ic coupling coefficient is achieved in an overall light weight iron free sys~em.
Referring now to FIGURE 2, the belt skin transformer (BST) comprising the primary winding 17 and the secondary winding 21 is driven by a BST driver, 23 ,' ' ' ~ ' , ' ~ .
~'' , . .' .,~ , ' ' ' ''' ' . ' ' 7~38~
more fully explained below. Power for the BST driver may be supplied fro~ any suitable source, such as a normal alternating current line, a vest battery, a car battery, etc. and is indicated generally by the element s 25 in FIGURE 2 As may be seen in ~'IGURE 2 and as is more specifically illustrated in FIGURE 3, the secondary windiny which has a plurality of parallel wires wound in a single turn with respect to the primary~ is coupled to a tertiary winding 27. It i5 preferable for all secondary windings to be parallel because: l) it is more reliable because of its redundancy; 2) the greatest potential between windings and tissue is less than one volt; 3) a simple single circuit connector can be used; 4) there is no danger of short circuits between windings of different potential.
It is preferable to space the wires for flexibility and because they thus form a wide "current sheet" which reduces formation of parasitic leakage fields (as around a small wire~ which would fail to couple with the primary belt.
Both windings 21 and 27 are wound on a common toroidal core 29. This particular design is useful in functioning as a current equalizing device. The separate equivalent transformers of the wixes of the ~ingle-turn coil 21 and the multi-turn coil 27 are interleaved in windings equally spaced around the core 29. Since these transformers are physically parts of the same core, they exhibit a very high coupling~ In fact, their individual coupling is typically about 98%.
Intercoupling between the windings, however, is typically only about 85%. Hence, there is a tendency toward a current equalization and thus a cancelling of local fields within the belt. This eliminates conductor degradation and electrical losses which might be encountered in the event of unbalanced surrents in the parallel wires of the single-turn coil 21.
, , ,: ' .
~ ~7~
Output from the winding 27l which will be more specifically described belowr is applied to a voltage regulator and battery switching circuit 31 which, in turn, drives the implanted device ll. A standby battery 33 is also used for periods in which the external power supply in the form of the BST driver 23 is temporarily disconnected. Suitable implanted telemetry circuitry 35 and external telemetry circuitry 37 are co~pled by telemetry pick-off units 3~ and 41, respectively, in order to permit monitoring and control of the implanted device by means of the monitor/control unit 39.
The implanted load or heart assist device ll is driven from the tertiary winding 27 by a pair of Schottky diodes 41 and 43, which are connected as full-wave rectifiers to the implanted load ll. The Schottky diodes are used to minimi~e voltage drop and may be of the type lN5825. The output voltage of the rectifier is smoothed by a capacitor 45 connected across the load. An auxiliary battery 47 is provided connected through a diode 49 across the load to supply auxiliary or standby power to the load. A switch and current regulating charge control 51 is provided for the battery 47 and may be of any suitable design to charge the battery from the positive portion of the rectified signal. Suitable signals may be developed from the implanted device to switch the charge control on and off. If the positive power to the implanted load drops below that of the battery 47 r the diode 49 conducts, providing the standby power to the load.
In order to internally regulate the power - provided to the implanted load, a shunt regulator is provided. The shunt regulator includes a reference voltage source 55 connected through a low voltage, low frequency sscillator 57 (sometimes known as a "dithern3 to a voltage comparator amplifier 59. The '' ': ' . - ':' . ~
~, ~ 2 ~7 ~
voltage output of the voltage comparator 59 is connected to the gates of a pair of SCR switches 61 and 63. ~he switches are connected across respective portions of the tertiary winding 27 and operate to shunt the output thereof, when the switches are closed, from the rectifying diodes 41 and 43, thus blocking the flow of power to the smoothing capacitor 45. During such periods the implanted load is supplied with power by discharge of the smoothing capacitor.
In operation, the shunt regulator is configured such that the switches 61 and 63 remain open whèn the voltage output of the rectifiers 41 and 43 is high enough to drive the load 11 and charge the battery 47~ when applicable. This voltage, which is near the 15 ref erence level 55, is sensed by the voltage comparator 59. When the voltage output of the diodes 41 and 43 exceeds the reference level, the voltage comparator 59 provides an output to the gates of the switches 61 and 63, turning the switches on (i.e. closing the switches). Under such circumstances, the tertiary winding 27 and hence the secondary winding 21 i5 effectively shorted. The frequency at which ~he switches 61 and 63 are operated is selected to be much lower than the power frequency in the tertiary winding 27 to minimi~e switching losses t simplify control and reduce undesirable harmonic generation. The oscillator 28 assists in ~he maintenance of the low frequency switching by causing the shunt regulator switching to occur at a predetermined fixed frequency, for example about 1 kHz, which simplifies the primary circuit regulator. As an alternative, the comparator 59 may be provided with a switching histeresis or dead band in accordance with known practice~
Referring now to FIGURE 4, the components of the BST driver 23 are illustrated. ~he primary winding 17 is connected via a capacitor 65 and series resis~or . ' ~ : ' ' ' ' :
.
..
~ ~8~
67 to ground. A pair of power switches couple a source of positive voltage ~for example a 12 volt automotive battery), or to ground. The power switches 69 and 71 are series connected with their junction being connected to one end of the primary winding 17. The primary winding 17 and the series capacitor 65 and resistor 67 form a series resonant circuit and the frequency at which the primary winding 17 is driven is determined by this resonance. Typically, this frequency will be approximately 80 kHz and will change in response to respiration and other mechanical factors effecting the inductance of the primary winding 17.
Phase lock of the driver circuit to the primary resonance is accomplished by switching the power circuit via the power switches 69 and 71 to the positive power source when zero current is detected.
This also facilitates self starting of the systemO
In order to drive the switches 69 and 71 at the desire~ frequerlcy, a driver circuit 73 is provided.
~ This driver circuit, which may be any suitable amplifier driver, is coupled to the gates of the switches 69 and 71 and is controlled such that the duration of the on time of the power switches 69 and 71 determines the duty cycle and therefore the total power which is applied to the primary winding 17.
In order to detect the current in the primary winding 17, the resistor 67 is connected to an amplifier 75 which develops a signal proportional to the current in the primary winding 17. This signal is applied ~hrough a comparator 77 and through a gate 79 o a flip-flop 81. The comparator 77 is a digital output comparator which develops a digital signal which is a square wave at a frequency which is in phase with the current in the primary winding 17. This digital ~5 signal sets the flip-~lop 81 through the gate 79, initiating a drive pulse from ~he flip-flop ~1 to the .
' , ', ' ' , " . ', ' , driver 73. The driver circuit 73 operates to amplify this pulse to control the switches 69 and 71 and to ensure that both switches cannot conduct simultaneously.
In order to control the width of the pulse output in the primary winding 17, the relative width of the pulse applied from the flip-flop 81 to the driver 73 is controlled. Since the power frequency may change, it is preferable to generate a pulse having a certain fraction of the period T = l/F, rather than a pulse of a fixed duration. In order to do this, a reference frequency is generatedl for example a reference of 32 x F. To this end, a preset counter 83 is provided connected to the gate 79 and the flip-flop 81. The counter, which may for example be industry type 4510, begins to count at the reference frequency (in the example 32F) when the gate 85, connected to the input of the preset counter 83, is enabled. When the preset count is reached, the flip-flop 81 is reset, ending the pulse to the driver 73 and thus turning off the power switches 69 and 71. The gate 79 operates to prevent the flip-flop 81 from turning on again, even if the signal output of the comparator 77 is still high.
When the signal output of the comparator 77 is low, an inverter 87, connected to the preset counter 83, resets the preset coun~er 83 to the preset number.
This preset number may be derived from an up-down counter 89, connected to the preset counter 83 and which may also be of the industry type 4510. On the basis of a reference frequency of 32 times the resonant frequency, the counter 83 may be set for a maximum count of 15. Thus, the 16th pulse will terminate the output of the driver 73. In this example, since the co~nter 83 is counting at a frequency of 32 times the resonant frequency, the greatest possible width Gf the output pulse is 50% o~ the period T = l/F, : ' ' , ' ~ ' .
.
corresponding to a full power square wave drive. Lower preset counts, of course, give narrower pulses of lower power level.
In order to derive the reference frequency from the signal output of the csmparator 77, a conventional phase lock loop 91 is utilized. Phase lock loops are generally well known in the art and may employ a simple binary counter and loop filter combined with other appropriate elements in a single chip, such as ind~stry type 215 or 565.
Voltage in the primary winding 17 is sensed by a differential amplifier 93. ~he amplifier 93 generates an analog of the voltage in the primary winding 17 which is then applied to a multiplier 95 ~for example, type 1496). The output from the amplifier 75 is also applied to the multiplier 32. The multiplier acts as a phase sensitive detector and its output has a substantial average value (DC component) if and only if the impedanc~ of the primary winding 17 has a substantial resistive component. The output of the multiplier 95 is fed through a low-pass filter 97 ~which removes product components of the resonant frequency of the primary winding 17 and higher frequencies) to a comparator 99. The comparator 99 is connected to an adjustable offset pot lOl which permits the threshold of the comparator 99 to be set sufficiently high as to reject output from the filter 97 resulting from noise and power dissipated ln the resistance of the belt skin transformer.
The output of the comparator is applied to two monostable multivibrators l~ and 105. Each of the monostable multivibra~ors 103 and lOS produces pulses of adjustable length "L" and "H", re~pectively. Æach multivibrator is connected to a variable resistor J 107 and lO9, respectively, which cons~itute part of the timing circuits of the multivibrators. For exampler , , ' . , ' ~ ' ~ ., . . . "
: , ~ ~37~
the multivibrators could be the two halves of a type 4528 chip. The dif~erence in settings between L and H
serves as a refractory or dead zone to help reject noise and prevent the implanted and primary regulators from interacting. The multivibrators control a pair of gates 111 and 113, respectively, which are connected to the up-down counter 89 and serve, as will be explained, to adjust the up-down counter 89 and therefore the preset counter 83 to control the width of the pulses in the primary winding 17.
Referring now more particularly to the operation of the device, as previously mentioned, when the shunt regulator in the implanted circuitry is open, the lsad which ~he primary winding 17 sees is primarily resistive. However, once the shunt regulator switches close, the load becomes primarily inductive. During the time that this shunt regulator is conducting current, current is circulating unproductively in the coils of the belt skin transformer, thus contributing to resistive losses. It is ~herefore desirable to adjust the power level in the primary winding as low as possible consistent with maintaining secondary shunt regulator control. In accordance with the invention, the conduction angle or power factor in the primary - ~5 winding 17 is sensed and the duty cycle of the primary drive pulse is controlled accordingly. Power factor is defined as cos p where ~ is the phase angle between current and voltage. A power factor of unity indicates the load is purely resistive.
More particularly, the multiplier 95 operates to compare and thus detect the phase relation between voltage and current in the primary winding 17. As such, the output signal of the multiplier 95 is high when the switches 61 and 63 are open reflecting a resistive load, and is low when the ~witches 61 and 63 are closed, reflecting an inductive load~ The output ~37 of the multiplier 95 is therefore a series of pulses of a frequency F fixed by the oscillator 57 and having a duty factor equal to the load conduction factor on the shunt regulator 61, 63O
Each positive ongoing edge of the p~lses represented by the output of the multiplier 95 triggers the monostable multivibrators 107 and 109. The output is a pair of pulses of length L and ~, respectively, the length of which is set by adjustment of the variable resistors 107 and 109. For example, if the frequency of the output of the multiplier 95 is 1 k~z, corresponding to a pulse period in the primary winding 17 of 1 millisecond, H might be set to 0.9 milliseconds and L might be set to 0~6 milliseconds. The difference between L and H, namely, 0.3 milliseconds, serves as the refractory or dead zone which minimizes interaction between the implanted and external regulators.
If the duration of each pulse in the output of the multiplier 95 is less than H but greater than L, the implanted shunt regulator is considered within its ideal operating range (60~ to 90% load conduction)l Neither of the gates 111 or 113 produce outputs. The number in the up~down counter 89 is unchanged and therefore the duty cycle of the pulse in the primary winding 17 is constant. If puls2 ~ ends before the end of the pulse from the multiplier 95, the gate 111 will produce an output which adds one count to the up-down counter 89 for each occurrence. Upon such occurrence, the width of the pulses in the primary winding 17 is increased, delivering more power to the implanted circuitry. On the other hand, if the pulse from the multiplier 95 ends before ~he pulse L~ the gate 113 will produ~e an ou~put which decreases the count in ~he ~ up~down counter 89 and thus reduces the width of the : 3S pulses applied to the primary winding 17. By such means, the power level reaching the secondary of the , .,, . ~ ;
: , ~ . ' - . ,' ' ~ ." . '' ' ~, '.. ' '' - '. ' ' : ' . . '~ ' ,. ' ' , ' ' . ' '' , ' '. : , . - , . . .
.
: , , ' " ' ' . ,' : . i ,, ' ~ ~7~
belt skin transformer is controlled so that the implanted regulator components can efficiently stabilize the belt skin transormer outp~t voltage.
It may be seen, therefore, that the system and method of the invention operate to effectively regulate the power levels applied to the implanted blood pump sys~em described. A two tier regulation scheme is employed wherein a shunt regulator in the implanted circuit controls the load vol~age and wherein a primary regulator senses the conduction angle of the shunt regulator and adjusts the primary power level, by changing the duty factor of the primary drive pulse.
Accordingly, unproductive circulation of current in the transcutaneous transformer and consequent resistive lS losses are minimized. As a consequence, close regulation of the power to the implanted device is achieved without the necessity of elaborate telemetry control.
Various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the - foregoing descrip~ion and accompanying drawings~ 5uch modific~tions are intended to fall wit~in the scope of the appended claims.
: . . . ,: : . .
., . . , : :
.. . -. -.
'. , ' : ' ';; ,' ~
,....... - . ~
~5 Schuder, et al. in the 1964 Transactions ACE~B.
However, difficulty has been experienced in reconciling .~.
,, . ~ :; .. ' : .
- , , .: .
. .
. , .
' .
~.~ 8 ~
the conflicting requirement of magnetic circuit geometry with a surgically feasible, variable tissue structure. In another proposed alternative design, a ~econdary coil is implanted in such a manner that the center of the coil remains accessible through a surgically constructed tunnel of skin; however, such devices have not yielded satisfactory performance.
Predominant failure modes include necrosis of the skin tunnel tissue caused by mechanical pressure and excess heat generation - see the 1975 report of I . I ,T.
Research Institute, by BruesGhke, et al., N.I~H. Report No. N01-HT-9-21~5-3, page 25.
In ~.S. Patent No. 4,143,661, issued ~arch 13, 1979, assigned to the assignee of the present invention, a so-called belt skin transformer ~BST~
system is described in which a secondary coil is implanted just below the skin of the abdomen or the thigh so that it encircles the patient's torso or leg along most of the length of the coil and lies at a location close to the skin's surface. A primary coil, in the form of an encircling belt which is greater in width than the secondary implanted coll, fits around the patient in the region just radially outward of the secondary coil. Power is supplied to the primary coil, which is then inductively coupled transcutaneously to the secondary coil, which in turn operates the device and charges and implanted storage battery~
Naturally, proper circuit design in a BST
system requires regulation of the voltage applied to the load or blood pump. Although a variety of regulatory expedients are known in the prior art, the uniqueness of the transcutaneous transformer arrangement employed in systems of this type makes the prior art of little value in predicting ideal arrangements~ X~ has been found that a ~wo tier regulation ~cheme, employing an internal regulator for , ..
, ~ .
~7~
driving the blood pump itself, and employing an external regulator for controlling voltage input to the primary winding, is particularly desirable.
Coordination of the two regulators may, of co~rse, be achieved by suitable telemetry signals. ~owever, such telemetry circuitry adds additional expense, complexity, and unreliability factors to the system.
It is an object of the present invention to provide an improved implanted blood pump system and method for operating same~
Another object of the invention is to provide an implanted blood pump system in which a highly effective means of voltage regulation is achieYed.
Another object of the invention is to provide 1~ an improved implanted blood pump system which coordinates regulation of the voltage applied to the system in accordance with load demands and without the need for telemetry monitoring.
Other objects of the invention will become apparent to those skilled in the art from the following description, taken in connection with the accompanying drawings ~herein:
- FIGURE 1 is a diagrammatic depiction of the implanted portion of a power supply system shown in ~S conjunction with a circulatory blood pump within a living human;
FIGURE 2 is a block diagram of the system illustrated in FIGURE l;
FIGURE 3 is a schematic diagram illustrating the secondary transformer of ~he system of FIGU~E 1 connected to rectifi~r, voltage regulator/ and other implanted elements including the blood pump itself (implanted load~; and FIGURE 4 is a schematic diagram of the primary winding power circuit utilized in the sy~tem of FIGURE
1 .
' .' :, , ' . ' ' ' ~ ' , ' : :, ..... ' - ' ' 9 ~78B~
~4--Very yenerally, in the implanted blood pump sy~tem of the invention, power for driving the pump is provided by a transcutaneous transformer having an external primary winding and an implanted secondary winding and an implanted shunt regulator. Ths secondary winding applies driving voltage to the pump which is controlled by the shunt regulator. The voltage applied to the system is regulated by sensing the power factor in the primary and comparing the power factor to a predetermined power factor level selected to correspond with a desired driving voltage~ The voltage level in the primary winding is adjusted to substantially equalize the sensed power factor and the predetermined power factor level.
Referring now more particularly to FIGURE 1, a blood pump in the form of a left ventricular assist device 11 is depicted implanted within the body 13 of a patient. The device is preferably of the type shown and described in U.S. Patents Nos. 4,4577673 and 4,384,829. The system also includes an implanted ; module 15 that includes electronic rectifying and control components and a standby storage battery.
The system is powered and charged via coupling to a primary coil which is constituted by an outer belt 17 having a disconnec~able belt buckle 19. A secondary coil, not visible in FIGURE 1, but designated as 21 in FIGURES 2 and 3 is implanted in the abdomen about the waist~ The primary coil 17 overlaps the secondary coil 21 and, when positioned about the waist o a wearer, is inductively coupled to the secondary coil 21. Because of the relatively large diameter of the two air core coils, a very high mayne~ic coupling coefficient is achieved in an overall light weight iron free sys~em.
Referring now to FIGURE 2, the belt skin transformer (BST) comprising the primary winding 17 and the secondary winding 21 is driven by a BST driver, 23 ,' ' ' ~ ' , ' ~ .
~'' , . .' .,~ , ' ' ' ''' ' . ' ' 7~38~
more fully explained below. Power for the BST driver may be supplied fro~ any suitable source, such as a normal alternating current line, a vest battery, a car battery, etc. and is indicated generally by the element s 25 in FIGURE 2 As may be seen in ~'IGURE 2 and as is more specifically illustrated in FIGURE 3, the secondary windiny which has a plurality of parallel wires wound in a single turn with respect to the primary~ is coupled to a tertiary winding 27. It i5 preferable for all secondary windings to be parallel because: l) it is more reliable because of its redundancy; 2) the greatest potential between windings and tissue is less than one volt; 3) a simple single circuit connector can be used; 4) there is no danger of short circuits between windings of different potential.
It is preferable to space the wires for flexibility and because they thus form a wide "current sheet" which reduces formation of parasitic leakage fields (as around a small wire~ which would fail to couple with the primary belt.
Both windings 21 and 27 are wound on a common toroidal core 29. This particular design is useful in functioning as a current equalizing device. The separate equivalent transformers of the wixes of the ~ingle-turn coil 21 and the multi-turn coil 27 are interleaved in windings equally spaced around the core 29. Since these transformers are physically parts of the same core, they exhibit a very high coupling~ In fact, their individual coupling is typically about 98%.
Intercoupling between the windings, however, is typically only about 85%. Hence, there is a tendency toward a current equalization and thus a cancelling of local fields within the belt. This eliminates conductor degradation and electrical losses which might be encountered in the event of unbalanced surrents in the parallel wires of the single-turn coil 21.
, , ,: ' .
~ ~7~
Output from the winding 27l which will be more specifically described belowr is applied to a voltage regulator and battery switching circuit 31 which, in turn, drives the implanted device ll. A standby battery 33 is also used for periods in which the external power supply in the form of the BST driver 23 is temporarily disconnected. Suitable implanted telemetry circuitry 35 and external telemetry circuitry 37 are co~pled by telemetry pick-off units 3~ and 41, respectively, in order to permit monitoring and control of the implanted device by means of the monitor/control unit 39.
The implanted load or heart assist device ll is driven from the tertiary winding 27 by a pair of Schottky diodes 41 and 43, which are connected as full-wave rectifiers to the implanted load ll. The Schottky diodes are used to minimi~e voltage drop and may be of the type lN5825. The output voltage of the rectifier is smoothed by a capacitor 45 connected across the load. An auxiliary battery 47 is provided connected through a diode 49 across the load to supply auxiliary or standby power to the load. A switch and current regulating charge control 51 is provided for the battery 47 and may be of any suitable design to charge the battery from the positive portion of the rectified signal. Suitable signals may be developed from the implanted device to switch the charge control on and off. If the positive power to the implanted load drops below that of the battery 47 r the diode 49 conducts, providing the standby power to the load.
In order to internally regulate the power - provided to the implanted load, a shunt regulator is provided. The shunt regulator includes a reference voltage source 55 connected through a low voltage, low frequency sscillator 57 (sometimes known as a "dithern3 to a voltage comparator amplifier 59. The '' ': ' . - ':' . ~
~, ~ 2 ~7 ~
voltage output of the voltage comparator 59 is connected to the gates of a pair of SCR switches 61 and 63. ~he switches are connected across respective portions of the tertiary winding 27 and operate to shunt the output thereof, when the switches are closed, from the rectifying diodes 41 and 43, thus blocking the flow of power to the smoothing capacitor 45. During such periods the implanted load is supplied with power by discharge of the smoothing capacitor.
In operation, the shunt regulator is configured such that the switches 61 and 63 remain open whèn the voltage output of the rectifiers 41 and 43 is high enough to drive the load 11 and charge the battery 47~ when applicable. This voltage, which is near the 15 ref erence level 55, is sensed by the voltage comparator 59. When the voltage output of the diodes 41 and 43 exceeds the reference level, the voltage comparator 59 provides an output to the gates of the switches 61 and 63, turning the switches on (i.e. closing the switches). Under such circumstances, the tertiary winding 27 and hence the secondary winding 21 i5 effectively shorted. The frequency at which ~he switches 61 and 63 are operated is selected to be much lower than the power frequency in the tertiary winding 27 to minimi~e switching losses t simplify control and reduce undesirable harmonic generation. The oscillator 28 assists in ~he maintenance of the low frequency switching by causing the shunt regulator switching to occur at a predetermined fixed frequency, for example about 1 kHz, which simplifies the primary circuit regulator. As an alternative, the comparator 59 may be provided with a switching histeresis or dead band in accordance with known practice~
Referring now to FIGURE 4, the components of the BST driver 23 are illustrated. ~he primary winding 17 is connected via a capacitor 65 and series resis~or . ' ~ : ' ' ' ' :
.
..
~ ~8~
67 to ground. A pair of power switches couple a source of positive voltage ~for example a 12 volt automotive battery), or to ground. The power switches 69 and 71 are series connected with their junction being connected to one end of the primary winding 17. The primary winding 17 and the series capacitor 65 and resistor 67 form a series resonant circuit and the frequency at which the primary winding 17 is driven is determined by this resonance. Typically, this frequency will be approximately 80 kHz and will change in response to respiration and other mechanical factors effecting the inductance of the primary winding 17.
Phase lock of the driver circuit to the primary resonance is accomplished by switching the power circuit via the power switches 69 and 71 to the positive power source when zero current is detected.
This also facilitates self starting of the systemO
In order to drive the switches 69 and 71 at the desire~ frequerlcy, a driver circuit 73 is provided.
~ This driver circuit, which may be any suitable amplifier driver, is coupled to the gates of the switches 69 and 71 and is controlled such that the duration of the on time of the power switches 69 and 71 determines the duty cycle and therefore the total power which is applied to the primary winding 17.
In order to detect the current in the primary winding 17, the resistor 67 is connected to an amplifier 75 which develops a signal proportional to the current in the primary winding 17. This signal is applied ~hrough a comparator 77 and through a gate 79 o a flip-flop 81. The comparator 77 is a digital output comparator which develops a digital signal which is a square wave at a frequency which is in phase with the current in the primary winding 17. This digital ~5 signal sets the flip-~lop 81 through the gate 79, initiating a drive pulse from ~he flip-flop ~1 to the .
' , ', ' ' , " . ', ' , driver 73. The driver circuit 73 operates to amplify this pulse to control the switches 69 and 71 and to ensure that both switches cannot conduct simultaneously.
In order to control the width of the pulse output in the primary winding 17, the relative width of the pulse applied from the flip-flop 81 to the driver 73 is controlled. Since the power frequency may change, it is preferable to generate a pulse having a certain fraction of the period T = l/F, rather than a pulse of a fixed duration. In order to do this, a reference frequency is generatedl for example a reference of 32 x F. To this end, a preset counter 83 is provided connected to the gate 79 and the flip-flop 81. The counter, which may for example be industry type 4510, begins to count at the reference frequency (in the example 32F) when the gate 85, connected to the input of the preset counter 83, is enabled. When the preset count is reached, the flip-flop 81 is reset, ending the pulse to the driver 73 and thus turning off the power switches 69 and 71. The gate 79 operates to prevent the flip-flop 81 from turning on again, even if the signal output of the comparator 77 is still high.
When the signal output of the comparator 77 is low, an inverter 87, connected to the preset counter 83, resets the preset coun~er 83 to the preset number.
This preset number may be derived from an up-down counter 89, connected to the preset counter 83 and which may also be of the industry type 4510. On the basis of a reference frequency of 32 times the resonant frequency, the counter 83 may be set for a maximum count of 15. Thus, the 16th pulse will terminate the output of the driver 73. In this example, since the co~nter 83 is counting at a frequency of 32 times the resonant frequency, the greatest possible width Gf the output pulse is 50% o~ the period T = l/F, : ' ' , ' ~ ' .
.
corresponding to a full power square wave drive. Lower preset counts, of course, give narrower pulses of lower power level.
In order to derive the reference frequency from the signal output of the csmparator 77, a conventional phase lock loop 91 is utilized. Phase lock loops are generally well known in the art and may employ a simple binary counter and loop filter combined with other appropriate elements in a single chip, such as ind~stry type 215 or 565.
Voltage in the primary winding 17 is sensed by a differential amplifier 93. ~he amplifier 93 generates an analog of the voltage in the primary winding 17 which is then applied to a multiplier 95 ~for example, type 1496). The output from the amplifier 75 is also applied to the multiplier 32. The multiplier acts as a phase sensitive detector and its output has a substantial average value (DC component) if and only if the impedanc~ of the primary winding 17 has a substantial resistive component. The output of the multiplier 95 is fed through a low-pass filter 97 ~which removes product components of the resonant frequency of the primary winding 17 and higher frequencies) to a comparator 99. The comparator 99 is connected to an adjustable offset pot lOl which permits the threshold of the comparator 99 to be set sufficiently high as to reject output from the filter 97 resulting from noise and power dissipated ln the resistance of the belt skin transformer.
The output of the comparator is applied to two monostable multivibrators l~ and 105. Each of the monostable multivibra~ors 103 and lOS produces pulses of adjustable length "L" and "H", re~pectively. Æach multivibrator is connected to a variable resistor J 107 and lO9, respectively, which cons~itute part of the timing circuits of the multivibrators. For exampler , , ' . , ' ~ ' ~ ., . . . "
: , ~ ~37~
the multivibrators could be the two halves of a type 4528 chip. The dif~erence in settings between L and H
serves as a refractory or dead zone to help reject noise and prevent the implanted and primary regulators from interacting. The multivibrators control a pair of gates 111 and 113, respectively, which are connected to the up-down counter 89 and serve, as will be explained, to adjust the up-down counter 89 and therefore the preset counter 83 to control the width of the pulses in the primary winding 17.
Referring now more particularly to the operation of the device, as previously mentioned, when the shunt regulator in the implanted circuitry is open, the lsad which ~he primary winding 17 sees is primarily resistive. However, once the shunt regulator switches close, the load becomes primarily inductive. During the time that this shunt regulator is conducting current, current is circulating unproductively in the coils of the belt skin transformer, thus contributing to resistive losses. It is ~herefore desirable to adjust the power level in the primary winding as low as possible consistent with maintaining secondary shunt regulator control. In accordance with the invention, the conduction angle or power factor in the primary - ~5 winding 17 is sensed and the duty cycle of the primary drive pulse is controlled accordingly. Power factor is defined as cos p where ~ is the phase angle between current and voltage. A power factor of unity indicates the load is purely resistive.
More particularly, the multiplier 95 operates to compare and thus detect the phase relation between voltage and current in the primary winding 17. As such, the output signal of the multiplier 95 is high when the switches 61 and 63 are open reflecting a resistive load, and is low when the ~witches 61 and 63 are closed, reflecting an inductive load~ The output ~37 of the multiplier 95 is therefore a series of pulses of a frequency F fixed by the oscillator 57 and having a duty factor equal to the load conduction factor on the shunt regulator 61, 63O
Each positive ongoing edge of the p~lses represented by the output of the multiplier 95 triggers the monostable multivibrators 107 and 109. The output is a pair of pulses of length L and ~, respectively, the length of which is set by adjustment of the variable resistors 107 and 109. For example, if the frequency of the output of the multiplier 95 is 1 k~z, corresponding to a pulse period in the primary winding 17 of 1 millisecond, H might be set to 0.9 milliseconds and L might be set to 0~6 milliseconds. The difference between L and H, namely, 0.3 milliseconds, serves as the refractory or dead zone which minimizes interaction between the implanted and external regulators.
If the duration of each pulse in the output of the multiplier 95 is less than H but greater than L, the implanted shunt regulator is considered within its ideal operating range (60~ to 90% load conduction)l Neither of the gates 111 or 113 produce outputs. The number in the up~down counter 89 is unchanged and therefore the duty cycle of the pulse in the primary winding 17 is constant. If puls2 ~ ends before the end of the pulse from the multiplier 95, the gate 111 will produce an output which adds one count to the up-down counter 89 for each occurrence. Upon such occurrence, the width of the pulses in the primary winding 17 is increased, delivering more power to the implanted circuitry. On the other hand, if the pulse from the multiplier 95 ends before ~he pulse L~ the gate 113 will produ~e an ou~put which decreases the count in ~he ~ up~down counter 89 and thus reduces the width of the : 3S pulses applied to the primary winding 17. By such means, the power level reaching the secondary of the , .,, . ~ ;
: , ~ . ' - . ,' ' ~ ." . '' ' ~, '.. ' '' - '. ' ' : ' . . '~ ' ,. ' ' , ' ' . ' '' , ' '. : , . - , . . .
.
: , , ' " ' ' . ,' : . i ,, ' ~ ~7~
belt skin transformer is controlled so that the implanted regulator components can efficiently stabilize the belt skin transormer outp~t voltage.
It may be seen, therefore, that the system and method of the invention operate to effectively regulate the power levels applied to the implanted blood pump sys~em described. A two tier regulation scheme is employed wherein a shunt regulator in the implanted circuit controls the load vol~age and wherein a primary regulator senses the conduction angle of the shunt regulator and adjusts the primary power level, by changing the duty factor of the primary drive pulse.
Accordingly, unproductive circulation of current in the transcutaneous transformer and consequent resistive lS losses are minimized. As a consequence, close regulation of the power to the implanted device is achieved without the necessity of elaborate telemetry control.
Various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the - foregoing descrip~ion and accompanying drawings~ 5uch modific~tions are intended to fall wit~in the scope of the appended claims.
: . . . ,: : . .
., . . , : :
.. . -. -.
'. , ' : ' ';; ,' ~
,....... - . ~
Claims (10)
1. In an implanted blood pump system wherein power for driving the pump is provided by a transcutaneous transformer having an external primary winding means and an implanted secondary winding means and shunt regulator means for controlling the driving voltage applied to the pump, a method for regulating the driving voltage applied to the primary winding means, comprising, sensing the power factor in the primary winding means, comparing the sensed power factor to a predetermined power factor level selected to correspond with a desired pump driving voltage, and adjusting the voltage level in the primary winding means to substantially equalize the sensed power factor and the predetermined power factor level.
2. A method according to Claim 1 wherein the power factor in the primary winding means is sensed by comparing the voltage and the current signals in the primary winding means and producing a control signal which is responsive to operation of the shunt regulator means.
3. A method according to Claim 1 wherein the voltage level in the primary winding means is adjusted by varying the width of pulses applied thereto.
4. An implantable blood pump system comprising, an implanted pump and a transcutaneous transformer having an external primary winding means and an implanted secondary winding means, said system further comprising implanted shunt regulator means for controlling the driving voltage applied to said pump, means for sensing the power factor in said primary winding means, means for comparing the sensed power factor to a predetermined power factor level selected to correspond with a desired driving voltage for said pump, and means for adjusting the voltage level in said primary winding means to substantially equalize the sensed power factor and the predetermined power factor level.
5. Apparatus according to Claim 4 wherein said power factor sensing means includes means for comparing the voltage and the current signals in said primary winding means and for producing a control signal which is responsive to operation of said shunt regulator means.
6. Apparatus according to Claim 4 including means for varying the width of pulses applied to said primary winding means to control the voltage level therein.
7. Apparatus according to Claim 4 wherein said shunt regulator means include switching means connected across said secondary winding means, and voltage comparator means for turning on said switching means when the voltage across said secondary winding means exceeds a predetermined level.
8. A system according to Claim 4 including an implanted battery connected to said pump and further including means for connecting said battery to said pump when the voltage across said secondary winding means falls below a preselected level.
9. Apparatus according to Claim 4 wherein said secondary winding means include first and second inductively coupled winding means, each of said first and second inductively coupled winding means being wound on a common toroidal core.
10. Apparatus according to Claim 9 wherein the said first winding means comprise a plurality of parallel first windings in which the currents are made equal in addition to being coupled to the second winding means, by being disposed about said toroidal core with equal spacing.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/757,786 US4665896A (en) | 1985-07-22 | 1985-07-22 | Power supply for body implant and method of use |
US757,786 | 1985-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1287881C true CA1287881C (en) | 1991-08-20 |
Family
ID=25049214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000513840A Expired - Lifetime CA1287881C (en) | 1985-07-22 | 1986-07-15 | Power supply for body implant |
Country Status (10)
Country | Link |
---|---|
US (1) | US4665896A (en) |
EP (1) | EP0231346B1 (en) |
JP (1) | JPH0761360B2 (en) |
AT (1) | ATE80024T1 (en) |
AU (1) | AU6191486A (en) |
BR (1) | BR8606805A (en) |
CA (1) | CA1287881C (en) |
DE (1) | DE3686648T2 (en) |
DK (1) | DK145887D0 (en) |
WO (1) | WO1987000420A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9192704B2 (en) | 2008-09-10 | 2015-11-24 | Heartware, Inc. | TET system for implanted medical device |
Families Citing this family (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4781716A (en) * | 1987-02-13 | 1988-11-01 | Marc Richelsoph | Artificial heart |
US5024224A (en) * | 1988-09-01 | 1991-06-18 | Storz Instrument Company | Method of readout of implanted hearing aid device and apparatus therefor |
US5085628A (en) * | 1988-09-09 | 1992-02-04 | Storz Instrument Company | Implantable hearing aid coupler device |
US4988333A (en) * | 1988-09-09 | 1991-01-29 | Storz Instrument Company | Implantable middle ear hearing aid system and acoustic coupler therefor |
US4968293A (en) * | 1989-03-20 | 1990-11-06 | Medtronic, Inc. | Circulatory assist device |
US5350413B1 (en) * | 1990-06-21 | 1999-09-07 | Heart Inst Research Corp | Transcutaneous energy transfer device |
DE4104359A1 (en) * | 1991-02-13 | 1992-08-20 | Implex Gmbh | CHARGING SYSTEM FOR IMPLANTABLE HOERHILFEN AND TINNITUS MASKERS |
US5344385A (en) * | 1991-09-30 | 1994-09-06 | Thoratec Laboratories Corporation | Step-down skeletal muscle energy conversion system |
US5193539A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5565005A (en) * | 1992-02-20 | 1996-10-15 | Amei Technologies Inc. | Implantable growth tissue stimulator and method operation |
EP0561068B1 (en) * | 1992-02-20 | 1999-03-03 | Neomedics, Inc. | Implantable bone growth stimulator |
US5411537A (en) * | 1993-10-29 | 1995-05-02 | Intermedics, Inc. | Rechargeable biomedical battery powered devices with recharging and control system therefor |
US5947892A (en) * | 1993-11-10 | 1999-09-07 | Micromed Technology, Inc. | Rotary blood pump |
US5524624A (en) * | 1994-05-05 | 1996-06-11 | Amei Technologies Inc. | Apparatus and method for stimulating tissue growth with ultrasound |
US5630836A (en) * | 1995-01-19 | 1997-05-20 | Vascor, Inc. | Transcutaneous energy and information transmission apparatus |
US5702431A (en) * | 1995-06-07 | 1997-12-30 | Sulzer Intermedics Inc. | Enhanced transcutaneous recharging system for battery powered implantable medical device |
US5690693A (en) * | 1995-06-07 | 1997-11-25 | Sulzer Intermedics Inc. | Transcutaneous energy transmission circuit for implantable medical device |
US5810015A (en) * | 1995-09-01 | 1998-09-22 | Strato/Infusaid, Inc. | Power supply for implantable device |
US5728154A (en) * | 1996-02-29 | 1998-03-17 | Minnesota Mining And Manfacturing Company | Communication method for implantable medical device |
AUPO214396A0 (en) * | 1996-09-04 | 1996-09-26 | Cochlear Pty. Limited | Compact inductive arrangement |
AU711002B2 (en) * | 1996-09-04 | 1999-10-07 | Cochlear Limited | Compact inductive arrangement |
US5713939A (en) * | 1996-09-16 | 1998-02-03 | Sulzer Intermedics Inc. | Data communication system for control of transcutaneous energy transmission to an implantable medical device |
US5749909A (en) * | 1996-11-07 | 1998-05-12 | Sulzer Intermedics Inc. | Transcutaneous energy coupling using piezoelectric device |
US5995874A (en) * | 1998-02-09 | 1999-11-30 | Dew Engineering And Development Limited | Transcutaneous energy transfer device |
US6331744B1 (en) | 1998-02-10 | 2001-12-18 | Light Sciences Corporation | Contactless energy transfer apparatus |
US6281611B1 (en) | 1998-02-10 | 2001-08-28 | Light Sciences Corporation | Use of moving element to produce heat |
US5945762A (en) * | 1998-02-10 | 1999-08-31 | Light Sciences Limited Partnership | Movable magnet transmitter for inducing electrical current in an implanted coil |
US6058330A (en) * | 1998-03-06 | 2000-05-02 | Dew Engineering And Development Limited | Transcutaneous energy transfer device |
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US6324431B1 (en) | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Transcutaneous energy transfer device with magnetic field protected components in secondary coil |
US6324430B1 (en) | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Magnetic shield for primary coil of transcutaneous energy transfer device |
US8489200B2 (en) | 1998-07-06 | 2013-07-16 | Abiomed, Inc. | Transcutaneous energy transfer module with integrated conversion circuitry |
US6389318B1 (en) * | 1998-07-06 | 2002-05-14 | Abiomed, Inc. | Magnetic shield for primary coil of transcutaneous energy transfer device |
FR2784585B1 (en) * | 1998-10-15 | 2001-01-26 | Gie Carmat | IMPLANTABLE HEART PROSTHESIS WITH INDEPENDENT VENTRICULAR CHAMBERS |
WO2000024456A1 (en) | 1998-10-27 | 2000-05-04 | Phillips Richard P | Transcutaneous energy transmission system with full wave class e rectifier |
US6442434B1 (en) * | 1999-10-19 | 2002-08-27 | Abiomed, Inc. | Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system |
US6579315B1 (en) | 2000-04-25 | 2003-06-17 | The Penn State Research Foundation | Artificial heart power supply system |
US6478820B1 (en) | 2000-04-25 | 2002-11-12 | The Penn State Research Foundation | Artificial heart with synchronous rectification |
US6395027B1 (en) | 2000-04-25 | 2002-05-28 | The Penn State Research Foundation | Artificial heart with arrhythmia signalling |
US6458164B1 (en) | 2000-04-25 | 2002-10-01 | The Penn State Research Foundation | Artificial heart with energy recovery |
US6451055B1 (en) | 2000-04-25 | 2002-09-17 | The Penn State Research Foundation | Artificial heart data communication system |
US6327504B1 (en) | 2000-05-10 | 2001-12-04 | Thoratec Corporation | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
US6808483B1 (en) | 2000-10-03 | 2004-10-26 | Paul A. Spence | Implantable heart assist devices and methods |
GB0106250D0 (en) * | 2001-03-13 | 2001-05-02 | Hall Effect Technologies Ltd | Apparatus and method for analysing blood |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
US7151378B2 (en) * | 2001-09-25 | 2006-12-19 | Wilson Greatbatch Technologies, Inc. | Implantable energy management system and method |
US8147544B2 (en) * | 2001-10-30 | 2012-04-03 | Otokinetics Inc. | Therapeutic appliance for cochlea |
US6772011B2 (en) | 2002-08-20 | 2004-08-03 | Thoratec Corporation | Transmission of information from an implanted medical device |
US7003353B1 (en) | 2002-12-10 | 2006-02-21 | Quallion Llc | Photovoltaic powered charging apparatus for implanted rechargeable batteries |
DE10302550B3 (en) * | 2003-01-22 | 2004-08-12 | Forschungszentrum Karlsruhe Gmbh | Belt reel as a transmit / receive antenna in a transponder device |
AU2003904032A0 (en) * | 2003-08-04 | 2003-08-14 | Ventracor Limited | Improved Transcutaneous Power and Data Transceiver System |
JP4153852B2 (en) * | 2003-09-18 | 2008-09-24 | オリンパス株式会社 | Energy supply coil and wireless in-vivo information acquisition system using the same |
US20050075696A1 (en) | 2003-10-02 | 2005-04-07 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US8140168B2 (en) | 2003-10-02 | 2012-03-20 | Medtronic, Inc. | External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore |
US20060034943A1 (en) * | 2003-10-31 | 2006-02-16 | Technology Innovations Llc | Process for treating a biological organism |
US20050288740A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous telemetry to implanted medical device |
US7599744B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Transcutaneous energy transfer primary coil with a high aspect ferrite core |
US7599743B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous energy transfer to implanted medical device |
US20050288739A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon, Inc. | Medical implant having closed loop transcutaneous energy transfer (TET) power transfer regulation circuitry |
US9192772B1 (en) | 2004-06-29 | 2015-11-24 | Quallion Llc | Portable medical power system |
US7828711B2 (en) * | 2004-08-16 | 2010-11-09 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular growth and regeneration using ventricular assist device |
US8073548B2 (en) * | 2004-08-24 | 2011-12-06 | Sensors For Medicine And Science, Inc. | Wristband or other type of band having an adjustable antenna for use with a sensor reader |
US20060089709A1 (en) * | 2004-10-21 | 2006-04-27 | Helmus Michael N | Medical implant with average surface charge density |
US7775966B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | Non-invasive pressure measurement in a fluid adjustable restrictive device |
US7927270B2 (en) | 2005-02-24 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | External mechanical pressure sensor for gastric band pressure measurements |
US8016744B2 (en) | 2005-02-24 | 2011-09-13 | Ethicon Endo-Surgery, Inc. | External pressure-based gastric band adjustment system and method |
US7699770B2 (en) | 2005-02-24 | 2010-04-20 | Ethicon Endo-Surgery, Inc. | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
US7775215B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device positioning and obtaining pressure data |
US7658196B2 (en) | 2005-02-24 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device orientation |
US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
US7502594B2 (en) * | 2005-04-27 | 2009-03-10 | Codman Neuro Sciences Sárl | Power regulation feedback to optimize robustness of wireless transmissions |
US7774069B2 (en) * | 2005-04-29 | 2010-08-10 | Medtronic, Inc. | Alignment indication for transcutaneous energy transfer |
KR101136889B1 (en) | 2005-07-12 | 2012-04-20 | 메사추세츠 인스티튜트 오브 테크놀로지 | Wireless non-radiative energy transfer |
US7825543B2 (en) * | 2005-07-12 | 2010-11-02 | Massachusetts Institute Of Technology | Wireless energy transfer |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
US8870742B2 (en) | 2006-04-06 | 2014-10-28 | Ethicon Endo-Surgery, Inc. | GUI for an implantable restriction device and a data logger |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
JP2009542359A (en) | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | Medical device with selective covering |
US8521303B2 (en) * | 2006-07-17 | 2013-08-27 | University Of Utah Reasearch Foundation | In vivo implantable coil assembly |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
EP2068757B1 (en) | 2006-09-14 | 2011-05-11 | Boston Scientific Limited | Medical devices with drug-eluting coating |
CA2663220A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
EP2068782B1 (en) | 2006-09-15 | 2011-07-27 | Boston Scientific Limited | Bioerodible endoprostheses |
EP2081616B1 (en) | 2006-09-15 | 2017-11-01 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
JP2010503491A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Bioerodible endoprosthesis with biologically stable inorganic layers |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
DE602007010669D1 (en) | 2006-12-28 | 2010-12-30 | Boston Scient Ltd | HREN FOR THIS |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
WO2008154387A1 (en) * | 2007-06-06 | 2008-12-18 | Worldheart Corporation | Wearable vad controller with reserve battery |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
JP2010533563A (en) | 2007-07-19 | 2010-10-28 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adsorption inhibiting surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8626297B2 (en) * | 2007-09-20 | 2014-01-07 | Boston Scientific Neuromodulation Corporation | Apparatus and methods for charging an implanted medical device power source |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8187163B2 (en) | 2007-12-10 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Methods for implanting a gastric restriction device |
US8100870B2 (en) | 2007-12-14 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Adjustable height gastric restriction devices and methods |
US8377079B2 (en) | 2007-12-27 | 2013-02-19 | Ethicon Endo-Surgery, Inc. | Constant force mechanisms for regulating restriction devices |
US8142452B2 (en) | 2007-12-27 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8192350B2 (en) | 2008-01-28 | 2012-06-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for measuring impedance in a gastric restriction system |
US8591395B2 (en) | 2008-01-28 | 2013-11-26 | Ethicon Endo-Surgery, Inc. | Gastric restriction device data handling devices and methods |
US8337389B2 (en) | 2008-01-28 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Methods and devices for diagnosing performance of a gastric restriction system |
US8221439B2 (en) | 2008-02-07 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using kinetic motion |
US7844342B2 (en) | 2008-02-07 | 2010-11-30 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using light |
US8114345B2 (en) | 2008-02-08 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | System and method of sterilizing an implantable medical device |
US8591532B2 (en) | 2008-02-12 | 2013-11-26 | Ethicon Endo-Sugery, Inc. | Automatically adjusting band system |
US8057492B2 (en) | 2008-02-12 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Automatically adjusting band system with MEMS pump |
US8034065B2 (en) | 2008-02-26 | 2011-10-11 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8187162B2 (en) | 2008-03-06 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Reorientation port |
US8233995B2 (en) | 2008-03-06 | 2012-07-31 | Ethicon Endo-Surgery, Inc. | System and method of aligning an implantable antenna |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
ES2950025T3 (en) * | 2008-10-10 | 2023-10-04 | Implantica Patent Ltd | Implant charger |
US8751001B2 (en) * | 2008-10-23 | 2014-06-10 | Medtronic, Inc. | Universal recharging of an implantable medical device |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US20110304240A1 (en) | 2008-12-21 | 2011-12-15 | Sirius Implantable Systems Ltd. | High efficiency piezoelectric micro-generator and energy storage system |
WO2010101901A2 (en) | 2009-03-02 | 2010-09-10 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US9555174B2 (en) | 2010-02-17 | 2017-01-31 | Flow Forward Medical, Inc. | Blood pump systems and methods |
KR101963799B1 (en) | 2010-02-17 | 2019-03-29 | 플로우 포워드 메디컬, 인크. | System and method to increase the overall diameter of veins |
US9662431B2 (en) | 2010-02-17 | 2017-05-30 | Flow Forward Medical, Inc. | Blood pump systems and methods |
US20110218622A1 (en) * | 2010-03-05 | 2011-09-08 | Micardia Corporation | Induction activation of adjustable annuloplasty rings and other implantable devices |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8766788B2 (en) | 2010-12-20 | 2014-07-01 | Abiomed, Inc. | Transcutaneous energy transfer system with vibration inducing warning circuitry |
DK2654878T3 (en) | 2010-12-20 | 2019-07-22 | Abiomed Inc | TRANSCUTANT ENERGY TRANSFER SYSTEM WITH A MULTIPLE OF SECONDARY COILS |
EP2654883B1 (en) | 2010-12-20 | 2022-09-14 | Abiomed, Inc. | Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system |
AU2012240239B2 (en) | 2011-04-04 | 2017-01-05 | Curonix Llc | Implantable lead |
EP3485819B1 (en) | 2011-04-14 | 2022-09-07 | Abiomed, Inc. | Transcutaneous energy transfer coil with integrated radio frequency antenna |
US8594804B2 (en) | 2011-04-28 | 2013-11-26 | Cyberonics, Inc. | Implantable medical device charging |
US9531195B2 (en) | 2011-04-29 | 2016-12-27 | Cyberonics, Inc. | Inductively rechargeable implantable device with reduced eddy currents |
RU2664156C2 (en) | 2011-08-17 | 2018-08-15 | Флоу Форвард Медикал, Инк., Сша | System and method for increase of outer diameter of viens and arteries |
BR112014003425B1 (en) | 2011-08-17 | 2020-12-15 | Flow Forward Medical, Inc | BLOOD CENTRIFUGAL PUMP SYSTEM |
US9343224B2 (en) * | 2011-08-19 | 2016-05-17 | Leviticus Cardio Ltd. | Coplanar energy transfer |
US9793579B2 (en) | 2013-11-08 | 2017-10-17 | Leviticus Cardio Ltd. | Batteries for use in implantable medical devices |
US20170216508A1 (en) * | 2011-08-19 | 2017-08-03 | Leviticus Cardio Ltd. | Coplanar wireless energy transfer |
US10543303B2 (en) | 2013-11-08 | 2020-01-28 | Leviticus Cardio Ltd. | Batteries for use in implantable medical devices |
US9642958B2 (en) | 2011-08-19 | 2017-05-09 | Leviticus Cardio Ltd. | Coplanar wireless energy transfer |
AU2012308197B2 (en) | 2011-09-15 | 2016-10-27 | Curonix Llc | Relay module for implant |
US9002468B2 (en) | 2011-12-16 | 2015-04-07 | Abiomed, Inc. | Automatic power regulation for transcutaneous energy transfer charging system |
KR101438887B1 (en) * | 2012-05-25 | 2014-11-03 | 엘지이노텍 주식회사 | Wireless power transmission device, power supplying device and power control method thereof |
US10258730B2 (en) | 2012-08-17 | 2019-04-16 | Flow Forward Medical, Inc. | Blood pump systems and methods |
US9254393B2 (en) * | 2012-12-26 | 2016-02-09 | Micron Devices Llc | Wearable antenna assembly |
US9192705B2 (en) * | 2013-03-25 | 2015-11-24 | Thoratec Corporation | Percutaneous cable with redundant conductors for implantable blood pump |
US9225194B2 (en) | 2013-04-24 | 2015-12-29 | Cyberonics, Inc. | Implantable medical device charging apparatus having both parallel and series resonators |
US9855376B2 (en) | 2014-07-25 | 2018-01-02 | Minnetronix, Inc. | Power scaling |
US10149933B2 (en) | 2014-07-25 | 2018-12-11 | Minnetronix, Inc. | Coil parameters and control |
EP3200846B1 (en) | 2014-10-01 | 2020-01-15 | Heartware, Inc. | Backup controller system with updating |
US10342908B2 (en) | 2015-01-14 | 2019-07-09 | Minnetronix, Inc. | Distributed transformer |
DE102016100534A1 (en) | 2015-01-16 | 2016-07-21 | Vlad BLUVSHTEIN | Data transmission in a transcutaneous energy transmission system |
US10193395B2 (en) | 2015-04-14 | 2019-01-29 | Minnetronix, Inc. | Repeater resonator |
CA3021657A1 (en) | 2016-04-29 | 2017-11-02 | Flow Forward Medical, Inc. | Conduit tips and systems and methods for use |
US20220080089A1 (en) * | 2020-09-15 | 2022-03-17 | Medtronic, Inc. | Coil shunting for voltage limiting of inductively transferred power |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3195540A (en) * | 1963-03-29 | 1965-07-20 | Louis C Waller | Power supply for body implanted instruments |
FR1379694A (en) * | 1963-09-18 | 1964-11-27 | Electronique Appliquee | Advanced cardiac exciter |
US3942535A (en) * | 1973-09-27 | 1976-03-09 | G. D. Searle & Co. | Rechargeable tissue stimulating system |
DE2720331A1 (en) * | 1977-05-06 | 1978-11-09 | Walter Holzer | Heart pacemaker with rechargeable battery - has transformer type recharging system and frequency sensor monitoring battery condition |
US4143661A (en) * | 1977-12-12 | 1979-03-13 | Andros Incorporated | Power supply for body implant and method for operation |
US4275739A (en) * | 1979-01-26 | 1981-06-30 | The Johns Hopkins University | Charge control switch responsive to cell casing deflection |
US4457673A (en) * | 1980-11-28 | 1984-07-03 | Novacor Medical Corporation | Pump and actuator mechanism |
US4384829A (en) * | 1980-11-28 | 1983-05-24 | Andros Incorporated | Pump and actuator mechanism |
US4548208A (en) * | 1984-06-27 | 1985-10-22 | Medtronic, Inc. | Automatic adjusting induction coil treatment device |
-
1985
- 1985-07-22 US US06/757,786 patent/US4665896A/en not_active Expired - Lifetime
-
1986
- 1986-07-15 CA CA000513840A patent/CA1287881C/en not_active Expired - Lifetime
- 1986-07-21 JP JP61504293A patent/JPH0761360B2/en not_active Expired - Lifetime
- 1986-07-21 DE DE8686905027T patent/DE3686648T2/en not_active Expired - Fee Related
- 1986-07-21 WO PCT/US1986/001546 patent/WO1987000420A1/en active IP Right Grant
- 1986-07-21 AU AU61914/86A patent/AU6191486A/en not_active Abandoned
- 1986-07-21 EP EP86905027A patent/EP0231346B1/en not_active Expired - Lifetime
- 1986-07-21 AT AT86905027T patent/ATE80024T1/en not_active IP Right Cessation
- 1986-07-21 BR BR8606805A patent/BR8606805A/en unknown
-
1987
- 1987-03-20 DK DK145887A patent/DK145887D0/en not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9192704B2 (en) | 2008-09-10 | 2015-11-24 | Heartware, Inc. | TET system for implanted medical device |
US9504775B2 (en) | 2008-09-10 | 2016-11-29 | Heartware, Inc. | TET system for implanted medical device |
US9770544B2 (en) | 2008-09-10 | 2017-09-26 | Christopher & Weisberg, P.A. | TET system for implanted medical device |
US10137232B2 (en) | 2008-09-10 | 2018-11-27 | Heartware, Inc. | TET system for implanted medical device |
US10413651B2 (en) | 2008-09-10 | 2019-09-17 | Heartware, Inc. | TET system for implanted medical device |
Also Published As
Publication number | Publication date |
---|---|
JPS63500288A (en) | 1988-02-04 |
EP0231346A4 (en) | 1989-07-11 |
WO1987000420A1 (en) | 1987-01-29 |
DE3686648T2 (en) | 1993-04-22 |
ATE80024T1 (en) | 1992-09-15 |
EP0231346B1 (en) | 1992-09-02 |
DE3686648D1 (en) | 1992-10-08 |
EP0231346A1 (en) | 1987-08-12 |
AU6191486A (en) | 1987-02-10 |
DK145887A (en) | 1987-03-20 |
US4665896A (en) | 1987-05-19 |
JPH0761360B2 (en) | 1995-07-05 |
DK145887D0 (en) | 1987-03-20 |
BR8606805A (en) | 1987-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1287881C (en) | Power supply for body implant | |
US10413651B2 (en) | TET system for implanted medical device | |
CA2510074C (en) | Medical implant having closed loop transcutaneous energy transfer (tet) power transfer regulation circuitry | |
US9125242B2 (en) | Selectable resonant frequency transcutaneous energy transfer system | |
Si et al. | A frequency control method for regulating wireless power to implantable devices | |
US3942535A (en) | Rechargeable tissue stimulating system | |
EP1051790B1 (en) | Automatic rate control for defibrillator capacitor charging | |
US5991665A (en) | Self-cooling transcutaneous energy transfer system for battery powered implantable device | |
US6442434B1 (en) | Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system | |
US5702431A (en) | Enhanced transcutaneous recharging system for battery powered implantable medical device | |
US5735887A (en) | Closed-loop, RF-coupled implanted medical device | |
US6745077B1 (en) | Electronic impedance transformer for inductively-coupled load stabilization | |
US6240318B1 (en) | Transcutaneous energy transmission system with full wave Class E rectifier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |